Passage Bio, Inc. (PASG)
4.75
-0.29
(-5.75%)
USD |
NASDAQ |
Sep 18, 16:00
4.70
-0.05
(-1.05%)
After-Hours: 20:00
Passage Bio Price to Book Value : 3.430 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 3.430 |
| September 17, 2026 | 3.640 |
| September 16, 2026 | 3.510 |
| September 15, 2026 | 3.444 |
| September 14, 2026 | 3.510 |
| September 11, 2026 | 3.611 |
| September 10, 2026 | 3.600 |
| September 09, 2026 | 3.567 |
| September 08, 2026 | 3.502 |
| September 04, 2026 | 3.358 |
| September 03, 2026 | 3.430 |
| September 02, 2026 | 3.329 |
| September 01, 2026 | 3.206 |
| August 31, 2026 | 3.199 |
| August 28, 2026 | 3.264 |
| August 27, 2026 | 3.127 |
| August 26, 2026 | 3.250 |
| August 25, 2026 | 3.488 |
| August 24, 2026 | 3.257 |
| August 21, 2026 | 3.206 |
| August 20, 2026 | 3.235 |
| August 19, 2026 | 3.257 |
| August 18, 2026 | 3.264 |
| August 17, 2026 | 3.278 |
| August 14, 2026 | 3.315 |
| Date | Value |
|---|---|
| August 13, 2026 | 3.304 |
| August 12, 2026 | 3.315 |
| August 11, 2026 | 3.250 |
| August 10, 2026 | 3.120 |
| August 07, 2026 | 3.177 |
| August 06, 2026 | 3.177 |
| August 05, 2026 | 3.329 |
| August 04, 2026 | 3.344 |
| August 03, 2026 | 3.242 |
| July 31, 2026 | 3.228 |
| July 30, 2026 | 3.242 |
| July 29, 2026 | 3.264 |
| July 28, 2026 | 3.300 |
| July 27, 2026 | 3.336 |
| July 24, 2026 | 3.567 |
| July 23, 2026 | 3.538 |
| July 22, 2026 | 3.553 |
| July 21, 2026 | 3.546 |
| July 20, 2026 | 3.473 |
| July 17, 2026 | 3.488 |
| July 16, 2026 | 3.546 |
| July 15, 2026 | 3.546 |
| July 14, 2026 | 3.206 |
| July 13, 2026 | 3.221 |
| July 10, 2026 | 3.300 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ARS Pharmaceuticals, Inc. | 32.66 |
| ACADIA Pharmaceuticals, Inc. | 3.595 |
| Alnylam Pharmaceuticals, Inc. | 23.66 |
| Anika Therapeutics, Inc. | 2.029 |
| Savara, Inc. | 7.678 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0087 |
| Price | 4.75 |
| Earnings Yield | -238.2% |
| Market Cap | 15.28M |
| PEGY Ratio | -0.0087 |